Navigation Links
Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011
Date:10/12/2011

CHADDS FORD, Pa., Oct. 12, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter 2011 financial results on October 27, 2011 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results.  

David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, Alan Levin, executive vice president and chief financial officer, and Blaine Davis, vice president, corporate affairs will host the call.

Investors and other interested parties may call 800-901-5241 (domestic) or 617-786-2963 (international) and enter passcode 11948354.  Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from October 27 at 12:00 p.m. ET until 12:00 p.m. ET on November 10 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 77092041.

A simultaneous webcast of the call may be accessed by visiting www.endo.com.  In addition, a replay of the webcast will be available until 12:00 p.m. ET on November 10.  The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries American Medical Systems, HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit http://www.endo.com/.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
2. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
3. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
4. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
5. Inovio Pharmaceuticals Leadership for Life Sciences Recognized in the Philadelphia Region
6. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
7. OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research
8. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
9. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
10. Top 450 Biotechnology (Pharmaceuticals) Report (Global)
11. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- KEY FINDINGS North America ... in 2016 and is expected to continue in the ... large number of surgical procedures that are taking place ... the patient temperature management market.) Patient warming and cooling ... blood during surgeries, lowering the risks of neurological disorders ...
(Date:12/8/2016)... -- Allergy Diagnostics Market: Scope and Methodology ... used to determine the presence of allergens such ... in the samples by determining the presence of ... on global allergy diagnostics market, analyzes the current ... consists of an executive summary that provides information ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced the addition ... their offering. ... This report analyzes the worldwide markets for Endodontic Supplies in US$ ... , Japan , Europe , ... World. Annual estimates and forecasts are provided for the period 2015 ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... Mediaplanet today announces distribution of the latest edition of “Transplants,” ... up as an organ donor for the 123,000 people in the United States who ... save up to 8 saves through organ donation and enhance many others through tissue ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... beginning January 1, 2017. The name change aligns the entire company with ... improving health care quality. , “We are very proud of the achievements associated ...
(Date:12/8/2016)... N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... December ... ... announce that Penn Medicine Southern Chester County, a Property owned by an affiliate ... $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center ...
(Date:12/8/2016)... ... ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced today the ... their world headquarters of Omni La Costa Resort & Spa in San Diego. , ... loss, personal development, a healthy lifestyle, or mental and physical healing. The week-long wellness ...
(Date:12/8/2016)... ... 2016 , ... STAT courier is pleased to announce that due to customer ... are expanding their presence in Dallas. One of the most exciting parts for STAT ... to the Dallas and Forth Worth market. STAT takes pride in treating their employees ...
Breaking Medicine News(10 mins):